<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chuang JC</submitter><funding>NCRR NIH HHS</funding><funding>NIDDK NIH HHS</funding><pagination>1482-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3138640</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>141(8)</volume><pubmed_abstract>Half-lives of α-tocopherol in plasma have been reported as 2-3 d, whereas the Elgin Study required >2 y to deplete α-tocopherol, so gaps exist in our quantitative understanding of human α-tocopherol metabolism. Therefore, 6 men and 6 women aged 27 ± 6 y (mean ± SD) ingested 1.81 nmol, 3.70 kBq of [5-(14)CH(3)]-(2R, 4'R, 8'R)-α-tocopherol. The levels of (14)C in blood plasma and washed RBC were monitored frequently from 0 to 460 d while the levels of (14)C in urine and feces were monitored from 0 to 21 d. Total fecal elimination (fecal + metabolic fecal) was 23.24 ± 5.81% of the (14)C dose, so feces over urine was the major route of elimination of the ingested [5-(14)CH(3)]-(2R, 4'R, 8'R)-α-tocopherol, consistent with prior estimates. The half-life of α-tocopherol varied in plasma and RBC a</pubmed_abstract><journal>The Journal of nutrition</journal><pubmed_title>Quantitation of [5-14CH3]-(2R, 4'R, 8'R)-α-tocopherol in humans.</pubmed_title><pmcid>PMC3138640</pmcid><funding_grant_id>R01 DK081551</funding_grant_id><funding_grant_id>P41 RR013461</funding_grant_id><funding_grant_id>R01 DK 081551</funding_grant_id><funding_grant_id>UL1 RR024146</funding_grant_id><funding_grant_id>RR13461</funding_grant_id><pubmed_authors>Chuang JC</pubmed_authors><pubmed_authors>Clifford AJ</pubmed_authors><pubmed_authors>Kim SH</pubmed_authors><pubmed_authors>Fadel JG</pubmed_authors><pubmed_authors>Nambiar KP</pubmed_authors><pubmed_authors>Holstege DM</pubmed_authors><pubmed_authors>Matel HD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Quantitation of [5-14CH3]-(2R, 4'R, 8'R)-α-tocopherol in humans.</name><description>Half-lives of α-tocopherol in plasma have been reported as 2-3 d, whereas the Elgin Study required >2 y to deplete α-tocopherol, so gaps exist in our quantitative understanding of human α-tocopherol metabolism. Therefore, 6 men and 6 women aged 27 ± 6 y (mean ± SD) ingested 1.81 nmol, 3.70 kBq of [5-(14)CH(3)]-(2R, 4'R, 8'R)-α-tocopherol. The levels of (14)C in blood plasma and washed RBC were monitored frequently from 0 to 460 d while the levels of (14)C in urine and feces were monitored from 0 to 21 d. Total fecal elimination (fecal + metabolic fecal) was 23.24 ± 5.81% of the (14)C dose, so feces over urine was the major route of elimination of the ingested [5-(14)CH(3)]-(2R, 4'R, 8'R)-α-tocopherol, consistent with prior estimates. The half-life of α-tocopherol varied in plasma and RBC a</description><dates><release>2011-01-01T00:00:00Z</release><publication>2011 Aug</publication><modification>2025-04-05T10:03:19.421Z</modification><creation>2019-03-27T03:07:12Z</creation></dates><accession>S-EPMC3138640</accession><cross_references><pubmed>21715470</pubmed><doi>10.3945/jn.111.138925</doi></cross_references></HashMap>